1. Home
  2. AM vs HALO Comparison

AM vs HALO Comparison

Compare AM & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Antero Midstream Corporation

AM

Antero Midstream Corporation

HOLD

Current Price

$17.66

Market Cap

8.5B

Sector

Utilities

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$67.12

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AM
HALO
Founded
2013
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
7.4B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
AM
HALO
Price
$17.66
$67.12
Analyst Decision
Hold
Buy
Analyst Count
3
12
Target Price
$18.83
$73.33
AVG Volume (30 Days)
2.7M
2.6M
Earning Date
10-29-2025
11-03-2025
Dividend Yield
5.14%
N/A
EPS Growth
20.98
56.68
EPS
0.98
4.74
Revenue
$1,249,571,000.00
$1,242,852,000.00
Revenue This Year
$4.60
$34.83
Revenue Next Year
$3.01
$24.84
P/E Ratio
$17.87
$14.22
Revenue Growth
8.70
31.19
52 Week Low
$14.31
$46.26
52 Week High
$19.82
$79.50

Technical Indicators

Market Signals
Indicator
AM
HALO
Relative Strength Index (RSI) 40.96 54.13
Support Level $17.56 $61.23
Resistance Level $18.05 $66.60
Average True Range (ATR) 0.38 2.03
MACD -0.07 0.28
Stochastic Oscillator 3.70 81.90

Price Performance

Historical Comparison
AM
HALO

About AM Antero Midstream Corporation

Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin located in West Virginia and Ohio. The company has two operating segments; the Gathering and Processing segment includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio and the Water Handling segment includes two independent systems that deliver water from sources including the Ohio River, local reservoirs and several regional waterways. It derives a majority of its revenue from the Gathering and Processing segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: